Alyeska Investment Group, L.P. A Tyr Pharma Inc Transaction History

Alyeska Investment Group, L.P.

$25.4 Billion
Q2 2025

A detailed history of Alyeska Investment Group, L.P. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,412,749 shares of LIFE stock, worth $2.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,412,749

Previous 1,277,897 10.55%

Holding current value

$2.63 Million

Previous $2.38 Million 10.56%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	N/A	134,852 Added 10.55%	1,412,749 $2.63 Million
Q1 2025 May 15, 2025	SELL	N/A	-544 Reduced 0.04%	1,277,897 $2.38 Million
Q4 2024 Feb 14, 2025	SELL	N/A	-450,097 Reduced 26.04%	1,278,441 $2.38 Million
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.24 $210,033 - $311,572	-139,095 Reduced 7.45%	1,728,538 $3.22 Million
Q2 2024 Aug 14, 2024	BUY	$0.0 - $2.07 $0 - $749,501	362,078 Added 24.05%	1,867,633 $2.91 Million
Q1 2024 May 15, 2024	SELL	$1.42 - $2.02 $1.35 Million - $1.92 Million	-950,000 Reduced 38.69%	1,505,555 $2.94 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.51 $277,500 - $377,500	250,000 Added 11.34%	2,455,555 $3.46 Million
Q2 2023 Aug 14, 2023	SELL	$1.72 - $2.57 $460,270 - $687,729	-267,599 Reduced 10.82%	2,205,555 $4.76 Million
Q1 2023 May 15, 2023	BUY	$1.88 - $2.5 $2.06 Million - $2.74 Million	1,094,407 Added 79.38%	2,473,154 $5.19 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $2.49 $606,000 - $747,000	300,000 Added 27.81%	1,378,747 $3.02 Million
Q3 2022 Nov 14, 2022	BUY	$2.79 - $4.15 $296,914 - $441,647	106,421 Added 10.94%	1,078,747 $3.24 Million
Q2 2022 Aug 15, 2022	BUY	$2.63 - $5.61 $556,318 - $1.19 Million	211,528 Added 27.8%	972,326 $2.75 Million
Q1 2022 May 16, 2022	BUY	$4.75 - $7.54 $407,659 - $647,105	85,823 Added 12.71%	760,798 $4.07 Million
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $3.02 Million - $3.93 Million	-413,689 Reduced 38.0%	674,975 $5.04 Million
Q3 2021 Nov 15, 2021	SELL	$4.22 - $12.48 $785,270 - $2.32 Million	-186,083 Reduced 14.6%	1,088,664 $9.89 Million
Q2 2021 Aug 16, 2021	BUY	$3.62 - $4.88 $1.05 Million - $1.42 Million	291,153 Added 29.6%	1,274,747 $6.22 Million
Q1 2021 May 17, 2021	BUY	$3.53 - $8.06 $497,871 - $1.14 Million	141,040 Added 16.74%	983,594 $4.38 Million
Q4 2020 Feb 16, 2021	BUY	$3.07 - $4.66 $276,017 - $418,971	89,908 Added 11.95%	842,554 $3.27 Million
Q3 2020 Nov 16, 2020	BUY	$3.23 - $5.39 $86,118 - $143,708	26,662 Added 3.67%	752,646 $2.43 Million
Q2 2020 Aug 14, 2020	SELL	$2.55 - $4.58 $31,375 - $56,352	-12,304 Reduced 1.67%	725,984 $3.22 Million
Q1 2020 May 15, 2020	BUY	$2.17 - $7.06 $1.6 Million - $5.21 Million	738,288 New	738,288 $2.07 Million

Others Institutions Holding LIFE

# of Institutions

116

Shares Held

49.8M

Call Options Held

743K

Put Options Held

485K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account

Alyeska Investment Group, L.P. A Tyr Pharma Inc Transaction History